Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 7.589\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] NC(=O)COC(=O)CC(c1ccccc1)c1ccccc1
[b] CC(=O)COc1ccc2oc(=O)cc(-c3cc4ccccc4o3)c2c1
[c] CCCn1nnnc1SCC(=O)NCc1ccc(OC)cc1
Answer: c. CCCn1nnnc1SCC(=O)NCc1ccc(OC)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1nnnc1SCC(=O)NCc1ccc(OC)cc1
CCCn1nnnc1SCC(=O)NCc1ccc(OC)cc1
N-[(4-methoxyphenyl)methyl]-2-(1-propyltetrazol-5-yl)sulfanylacetamide